Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCue Biopharma, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Cue Biopharma, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $7.88M. Net result −$153.07M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $7.88M. Running result $7.88M. Revenue: $7.88M.
  • Cost of revenue: $0. Running result $7.88M.
  • Gross profit: $7.88M. Running result $7.88M.
  • General and administrative: −$46.57M. Running result −$38.69M.
  • Research and development: −$49.01M. Running result −$87.7M.
  • Gain on lease termination: $0. Running result −$87.7M.
  • Operating income: −$87.7M. Running result −$87.7M.
  • Other expense: −$65.37M. Running result −$153.07M.
  • Pre-tax loss: −$153.07M. Running result −$153.07M.
  • Income tax benefit: $0. Running result −$153.07M.
  • Net loss: −$153.07M. Running result −$153.07M.